Breast Cancer In Young Women
Programs Breast Cancer In Young Women Breast Cancer In Young Women Get Involved Partners And Sponsors Community Donate
Clinical Trials
Participating in clinical trials is one of the most meaningful actions we, as members of this community of young women, can take to help each other. Working together with medical researchers, we have the power to ensure good data that’s relevant to us all—while answering those questions that continue to confound young women and doctors alike.
More than Numbers, But Young Women Better Be Counted
By participating, you’ll join the ranks of numerous YSC constituents already playing a vital role in breast-cancer research. Personally, depending on the stage of the trial you join, your own fight against cancer might get a boost from new treatments—long before they become standard. Read more about the benefits of participation here.
RSS: Breast Cancer in Young Women Clinical Trials
Studies found on ClinicalTrials.gov by a search of: breast cancer young women | updated in the last 30 days
The Efficacy of Health Partnership Program for Cancer Patients
Conditions: Breast Cancer; Colon Cancer; Gastric Cancer; Lung CancerInterventions: Behavioral: Tailored health partnership program; Behavioral: Usual care and health education workshop
Sponsors: National Cancer Center, Korea; Samsung Medical Center; Seoul National University Hospital; Korea University Anam Hospital; Asan Medical Center; Ajou University School of Medicine; Kyunghee University Medical Center
Recruiting - verified February 2012
Tue, 10 Jan 2012 12:00:00 EST
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Condition: Breast CancerInterventions: Biological: trastuzumab; Drug: cyclophosphamide; Drug: docetaxel; Drug: doxorubicin hydrochloride; Drug: paclitaxel
Sponsors: National Surgical Adjuvant Breast and Bowel Project (NSABP); National Cancer Institute (NCI)
Recruiting - verified February 2012
Tue, 11 Jan 2011 12:00:00 EST
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Condition: Breast CancerInterventions: Drug: anastrozole; Drug: exemestane; Drug: letrozole; Drug: systemic chemotherapy; Drug: tamoxifen citrate
Sponsors: Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting - verified February 2012
Thu, 06 Jan 2011 12:00:00 EST
Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction
Condition: Breast CancerInterventions: Drug: Tamoxifen Citrate; Drug: Placebo
Sponsors: City of Hope Medical Center; National Cancer Institute (NCI); St. Jude Children's Research Hospital; University Health Network, Toronto; Emory University; University of Michigan
Recruiting - verified February 2012
Fri, 03 Sep 2010 12:00:00 EDT
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Condition: Lung CancerInterventions: Biological: bevacizumab; Biological: cetuximab; Drug: carboplatin; Drug: paclitaxel
Sponsors: Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting - verified February 2012
Fri, 24 Jul 2009 12:00:00 EDT
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
Conditions: Breast Cancer; Metastatic Cancer; Multiple Myeloma and Plasma Cell Neoplasm; Musculoskeletal Complications; Pain; Prostate Cancer; Urinary ComplicationsIntervention: Drug: zoledronic acid
Sponsors: Cancer and Leukemia Group B; National Cancer Institute (NCI)
Recruiting - verified February 2012
Tue, 24 Mar 2009 12:00:00 EDT
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Condition: Breast CancerInterventions: Biological: trastuzumab; Radiation: radiation therapy
Sponsors: National Surgical Adjuvant Breast and Bowel Project (NSABP); National Cancer Institute (NCI)
Recruiting - verified February 2012
Wed, 08 Oct 2008 12:00:00 EDT
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Condition: Head and Neck CancerInterventions: Biological: bevacizumab; Drug: carboplatin; Drug: cisplatin; Drug: docetaxel; Drug: fluorouracil
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Recruiting - verified February 2012
Fri, 28 Dec 2007 12:00:00 EST
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Condition: Lung CancerInterventions: Biological: bevacizumab; Drug: cisplatin; Drug: docetaxel; Drug: gemcitabine hydrochloride; Drug: pemetrexed disodium; Drug: vinorelbine tartrate
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI); Southwest Oncology Group; Cancer and Leukemia Group B; NCIC Clinical Trials Group; North Central Cancer Treatment Group
Recruiting - verified February 2012
Wed, 10 May 2006 12:00:00 EDT
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Condition: Breast CancerInterventions: Radiation: 3-dimensional conformal accelerated partial breast irradiation; Radiation: brachytherapy; Radiation: whole breast irradiation
Sponsors: National Surgical Adjuvant Breast and Bowel Project (NSABP); National Cancer Institute (NCI); Radiation Therapy Oncology Group; Southwest Oncology Group
Recruiting - verified February 2012
Mon, 07 Feb 2005 12:00:00 EST
RSS: Breast Cancer Clinical Trials
Studies found on ClinicalTrials.gov by a search of: Breast Cancer | updated in the last 30 days
An Observational Study to Register the Incidence of Breast Cancer and Current Clinical Care Patterns in Kenya
Condition: Breast CancerIntervention:
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2012
Mon, 19 Sep 2011 12:00:00 EDT
Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer
Conditions: Tubular Breast Cancer Stage II; Mucinous Breast Cancer Stage II; Breast Cancer Female NOS; Invasive Ductal Breast Cancer; Tubular Breast Cancer Stage III; HER-2 Positive Breast Cancer; Inflammatory Breast Cancer Stage IV; Inflammatory Breast CancerInterventions: Drug: Carboplatin; Drug: background treatment according to standards fpr triple negative and Her2pos breast cancer patients
Sponsors: German Breast Group; Cephalon; Roche Pharma AG; GlaxoSmithKline
Recruiting - verified September 2011
Wed, 17 Aug 2011 12:00:00 EDT
Bilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breast Cancer and Their Families or Caregivers
Conditions: Breast Cancer; Ductal Breast Carcinoma in Situ; Stage I Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast CancerInterventions: Other: educational intervention; Procedure: quality-of-life assessment; Other: Questionnaire Administration; Other: psychosocial support for caregiver; Procedure: assessment of therapy complications; Other: informational intervention
Sponsor: City of Hope Medical Center
Completed - verified January 2012
Mon, 04 Jan 2010 12:00:00 EST
Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer
Condition: Breast CancerInterventions: Biological: allogeneic GM-CSF-secreting breast cancer vaccine; Biological: trastuzumab; Drug: cyclophosphamide
Sponsors: Sidney Kimmel Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified January 2012
Thu, 03 Sep 2009 12:00:00 EDT
Developing Mouse Models of Breast Cancer Using Tissue Samples From Women With Breast Cancer
Condition: Breast CancerInterventions: Other: laboratory biomarker analysis; Other: medical chart review
Sponsors: Vanderbilt-Ingram Cancer Center; National Cancer Institute (NCI)
Recruiting - verified February 2012
Sat, 09 May 2009 12:00:00 EDT
Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer
Condition: Breast CancerInterventions: Biological: allogeneic GM-CSF-secreting breast cancer vaccine; Biological: trastuzumab; Drug: cyclophosphamide; Other: flow cytometry; Other: immunoenzyme technique; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: biopsy
Sponsors: Sidney Kimmel Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified January 2012
Wed, 18 Feb 2009 12:00:00 EST
Cognitive Changes Associated With Breast Cancer Treatment
Conditions: Breast Cancer; Cognitive Side Effects of Cancer Treatments; Stage I, II and III A Breast CancerInterventions: Behavioral: Questionnaires, MRI, Comet assay and Cell senescence; Behavioral: Questionnaires, MRI, Comet assay and Cell senescence; Behavioral: Questionnaires, MRI, Comet assay and Cell senescence
Sponsors: Memorial Sloan-Kettering Cancer Center; Weill Medical College of Cornell University; The City College of New York; Brigham and Women's Hospital
Recruiting - verified February 2012
Thu, 25 Oct 2007 12:00:00 EDT
Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women
Condition: Breast CancerInterventions: Other: physiologic testing; Other: screening questionnaire administration; Procedure: breast imaging study; Procedure: radiomammography; Procedure: study of high risk factors
Sponsors: Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified February 2012
Wed, 07 Mar 2007 12:00:00 EST
Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer
Condition: Breast NeoplasmsInterventions: Biological: Allogeneic GM-CSF-secreting breast cancer vaccine; Drug: Trastuzumab; Drug: Cyclophosphamide
Sponsors: Sidney Kimmel Comprehensive Cancer Center; American Cancer Society; Avon Foundation; Cancer Treatment Research Foundation; Commonwealth Foundation; Department of Defense; Genentech
Completed - verified January 2012
Mon, 13 Nov 2006 12:00:00 EST
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Condition: Breast CancerInterventions: Radiation: 3-dimensional conformal accelerated partial breast irradiation; Radiation: brachytherapy; Radiation: whole breast irradiation
Sponsors: National Surgical Adjuvant Breast and Bowel Project (NSABP); National Cancer Institute (NCI); Radiation Therapy Oncology Group; Southwest Oncology Group
Recruiting - verified February 2012
Mon, 07 Feb 2005 12:00:00 EST
Info Just for you
